↓ Skip to main content

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Overview of attention for article published in New England Journal of Medicine, September 2021

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
51 news outlets
blogs
2 blogs
policy
1 policy source
twitter
132 X users
patent
1 patent
facebook
2 Facebook pages
reddit
4 Redditors
guideline
12 clinical guideline sources
podcasts
2 podcasts

Readers on

mendeley
638 Mendeley